| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/22/1989 | EP0308147A1 Hyposensitization agent |
| 03/22/1989 | EP0307976A1 Mycoplasma vaccine |
| 03/22/1989 | EP0307754A2 Method for obtaining a papain-free antibody fragment preparation |
| 03/22/1989 | EP0307480A1 Process for preparing antibody complex |
| 03/21/1989 | US4814433 Method for obtaining a papain-free antibody fragment preparation |
| 03/21/1989 | US4814277 Method of inactivating reproductive filterable pathogens |
| 03/21/1989 | US4814268 Methods for propagating fastidious human viruses and for producing purified suspensions thereof |
| 03/21/1989 | US4814170 Method for immunization against and treatment of infection by ectoparasites and endoparasites |
| 03/21/1989 | US4814169 Innoculating animals, spleen cells, immunology |
| 03/21/1989 | US4813924 Drugs, haptens, antigens, antibodies |
| 03/21/1989 | CA1251401A1 Method for preparation of herpes simplex virus subunit vaccine |
| 03/21/1989 | CA1251400A1 Method for purification of japanese encephalitis virus |
| 03/21/1989 | CA1251399A1 Method for purification of influenza virus |
| 03/21/1989 | CA1251398A1 Method for purification of rabic virus |
| 03/21/1989 | CA1251397A1 Live purified marek's disease vaccine |
| 03/21/1989 | CA1251396A1 Vaccines comprising immunogenic protein or peptide complexes |
| 03/21/1989 | CA1251394A1 Method for preparing coating compositions containing an immunologically reactive species and elements containing same |
| 03/15/1989 | EP0306995A2 Tumor immunotherapy using anti-idiotypic antibodies |
| 03/15/1989 | EP0306971A2 Use of milk fat globules as carriers for drugs and as microflotation devices in immunoassays and cell/molecular fractionation |
| 03/15/1989 | EP0306943A2 Immunconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
| 03/15/1989 | EP0306912A2 Immunogenic composites capable of selectively inducing antibody production and pharmaceutical compositions employing the same. |
| 03/15/1989 | EP0306797A2 Dispersion polymers, process for their preparation and their use |
| 03/15/1989 | EP0306607A1 Vaccines for gram-negative bacteria |
| 03/15/1989 | EP0306524A1 Antigenic determinants recognized by antibodies obtained using a pathogenic agent or a derivative thereof that presents a restricted set of antigens |
| 03/15/1989 | EP0113712B1 Polypeptide active immunosuppressant fraction |
| 03/14/1989 | US4812559 Vaccine against varicella-zoster virus |
| 03/14/1989 | CA1251135A1 Anti-mastitis polyvalent vaccine, method of administration and method for production thereof |
| 03/14/1989 | CA1251134A1 Biologically active substance with hormonal properties, process for its production and application of histones for medical purposes |
| 03/09/1989 | WO1989001976A1 Recombinant dna-derived bordetella toxin subunit analogs |
| 03/09/1989 | WO1989001975A1 Recombinant antibodies and methods for their production |
| 03/09/1989 | WO1989001974A1 Recombinant antibody |
| 03/09/1989 | WO1989001973A2 Recombinant pox virus for immunization against tumor-associated antigens |
| 03/09/1989 | WO1989001943A1 Peptide complexes having enhanced stability |
| 03/09/1989 | WO1989001940A1 Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins |
| 03/09/1989 | WO1989001785A1 Monoclonal antibodies to a plasmodium falciparum protein |
| 03/09/1989 | WO1989001784A1 Production of immunoproximity catalysts |
| 03/09/1989 | WO1989001783A2 Recombinant antibody and method |
| 03/09/1989 | WO1989001782A1 Recombinant antibody |
| 03/09/1989 | WO1989001773A1 Synovial phospholipases |
| 03/08/1989 | EP0306473A1 Pharmaceutical structure with protein-supported agents |
| 03/08/1989 | EP0306360A1 Method for the preparation of antigenic fractions used in the detection of antibodies indicative of cardiovascular trouble, antigenic fractions thus obtained and their use in the diagnosis of a cardiovascular risk |
| 03/08/1989 | EP0306318A1 Recombinant DNA-derived bordetella toxin subunit analogs |
| 03/08/1989 | EP0306303A1 Anti-viral neoantigen antibodies and anti-idiotypic antibodies induced thereby as anti-viral agents |
| 03/08/1989 | EP0306219A2 Novel HIV proteins and peptides useful in the diagnosis, prophylaxis or therapy of AIDS |
| 03/08/1989 | EP0306168A1 Preparation of radiolabeled conjugates |
| 03/08/1989 | EP0305967A2 Conjugates of interferon alpha with immunoglobulins |
| 03/08/1989 | EP0305960A2 A transformant cell line capable of producing a human monoclonal antibody, hybridoma, their production and use |
| 03/08/1989 | EP0305870A2 Production of immunoproximity catalysts |
| 03/08/1989 | EP0305777A2 Synthesis of human immunodeficiency virus type 1 antigens and their use as diagnostic and therapeutic agents |
| 03/08/1989 | EP0305468A1 B-cell growth and differentiating factor BCGF 12K for use in therapy |
| 03/08/1989 | CN1031539A Process for preparing particules of polymer by immodile molecales amphiphiles portion with ionise or active group on surface or latex constitues thereof |
| 03/08/1989 | CN1031479A Swine dysentery vaccine |
| 03/07/1989 | US4810781 Immunology, monoclonal antibodies, complexing, fragmentation |
| 03/07/1989 | US4810634 Pseudorabies virus mutants incapable of producing glycoprotein X |
| 03/07/1989 | US4810494 Canine parvovirus vaccines |
| 03/07/1989 | US4810493 Method for the culture of the TRT/SHS virus, and vaccine therefrom, especially for the treatment of turkeys |
| 03/07/1989 | US4810492 Vaccine against japanese encephalitis |
| 03/07/1989 | US4810491 Polypeptides useful in vaccination against enteroviruses |
| 03/07/1989 | CA1251000A1 Dipeptides, process for the preparation thereof and pharcameutical preparations containing them |
| 03/01/1989 | EP0305320A2 Multinucleic substituted complexants, complexes and complex salts, process for their preparation and pharmaceutical agents containing them |
| 03/01/1989 | EP0305279A1 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
| 03/01/1989 | EP0305229A1 Viral vector and recombinant DNA encoding one or more structural proteins (HA,F and/or NP) of a morbillivirus |
| 03/01/1989 | EP0304897A2 Process for immunizing the human body at HIV infections |
| 03/01/1989 | EP0304786A2 Intranasal vaccination of horses with inactivated microorganisms or antigenic materials |
| 03/01/1989 | EP0304578A1 Peptide comprising hepatitis B surface antigen |
| 03/01/1989 | CN1031395A Hepatitis b virus surface antigens and hybrid antigens containing them |
| 03/01/1989 | CN1031328A Intracasal immunization against viral infection using viral glycoprotein subunit vaccine |
| 02/28/1989 | US4808705 Using glycerol, albumin, and dextran sulfate |
| 02/28/1989 | US4808700 Vaccine for immunization of young mammals against infections |
| 02/28/1989 | US4808536 Human t-cell lymphotropic virus; acquired immunodeficiency syndrome; in kit form; screening |
| 02/28/1989 | US4808521 Incubation, separation components containing first and second enzyme, comparing to standard |
| 02/28/1989 | US4808404 Live vaccine for coccidiosis utilizing coccidial sporozoites |
| 02/28/1989 | CA1250587A1 Method and agents for measuring protein aging |
| 02/28/1989 | CA1250524A1 Preparation and use of enzyme-detergent extracted streptococcus equi vaccine |
| 02/23/1989 | WO1989001629A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
| 02/23/1989 | WO1989001628A1 Monoclonal antibodies reactive with cytomegalovirus glycoprotein a |
| 02/23/1989 | WO1989001516A1 Vaccines whose characteristic epitope is incorporated into a protein of picornavirus, in particular, poliovirus |
| 02/23/1989 | WO1989001514A1 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine |
| 02/23/1989 | WO1989001511A1 Suppressive t lymphocyte cell lines and supernatant derivative thereof |
| 02/23/1989 | WO1989001494A1 Hiv-1-related polypeptides, diagnostic systems and assay methods |
| 02/23/1989 | WO1989001490A2 Biologically active molecules |
| 02/23/1989 | WO1989001476A1 Tetra-aza macrocycles and metal complexes thereof |
| 02/23/1989 | WO1989001475A1 Tri-aza macrocycles and metal complexes thereof |
| 02/23/1989 | WO1989001343A1 Cationized antibodies for delivery through the blood-brain barrier |
| 02/23/1989 | WO1989001340A1 Method for treating malignancy and autoimmune disorders in humans |
| 02/23/1989 | WO1989001339A1 Hyper-immune globulin against hiv |
| 02/23/1989 | WO1989001338A1 Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome |
| 02/23/1989 | WO1989001337A1 Methods and compositions for mimicking antigenic determinants |
| 02/23/1989 | WO1989001335A1 Biospecific polymers |
| 02/22/1989 | EP0304344A1 Viruses related to the hepatitis B virus, their constituents and their use as a vaccine or diagnostic reagent |
| 02/22/1989 | EP0304291A1 Dosage form using an antagonist to gamma interferon to control MHC-associated autoimmune disease |
| 02/22/1989 | EP0304279A2 Peptide determinant associated with immunity |
| 02/22/1989 | EP0304238A2 Method for detecting and confirming the presence of antibodies |
| 02/22/1989 | EP0304161A2 Separation of immunoglobulin G subclasses |
| 02/22/1989 | EP0303983A2 Synthetic peptides, antibodies directed against them and their use |
| 02/22/1989 | EP0303980A2 Carrier coated with antigen or antibody |
| 02/22/1989 | EP0303692A1 Cloning of lfa-1 |
| 02/21/1989 | US4807177 Multiple format hand held label printer |
| 02/21/1989 | US4806492 Polypeptide tumor inhibitors and antibodies thereto |
| 02/21/1989 | US4806352 Mixture of oil, alcohol, lecithin and detoxification bacteria |